חוב כולל של החברה: trisaluslifesci.com (TLSI)

TriSalus Life Sciences (TLSI) holds unique patents for the pressurized transport of drugs into tumors, which, combined with FDA certifications, blocks competitors from entering this niche. The company's price evolution on GURU.Markets reflects debt dynamics, which currently stand at 0.03. Financial stability remains fragile due to colossal research and development expenditures and the slow growth of commercial revenues.

TriSalus Life Sciences verified supply chains minimize operational disruptions, establishing a foundation for capital management. This financial obligations chart aggregates the total volume of loans, measuring the business's reliance on borrowed funds and its resilience to rising rates. This indicator's trend allows for a real-time assessment of interest rate shock risks. It is critical for investors to correlate this data with revenue to understand solvency. The final debt balance directly impacts market capitalization.